Iron-overload links to genetic instability in myelodysplastic syndromes

被引：0

作者：

Westhofen, G. ^{[1
,2
]}

Ganster, C. ^{[1
,2
]}

Beyer, F. ^{[3
]}

Rassaf, T. ^{[4
]}

Al-Ali, H. K. ^{[5
]}

Stuhlmann, R. ^{[6
]}

Glass, B. ^{[6
]}

Bacher, U. ^{[1
,2
]}

Bruemmendorf, T. ^{[3
]}

Germing, U. ^{[7
]}

Gattermann, N. ^{[7
]}

Haase, D. ^{[1
,2
]}

机构：

[1] Univ Med Gottingen, Specialized Diagnost Labs INDIGHO, Clin Hematol, Gottingen, Germany

[2] Univ Med Gottingen, Specialized Diagnost Labs INDIGHO, Clin Med Oncol, Gottingen, Germany

[3] RWTH Aachen Univ Hosp, Dept Haematol Oncol Haemostaseol & Stem Cell Tran, Aachen, Germany

[4] Univ Dusseldorf, Dept Cardiol, Pneumol, Angiol, Dusseldorf, Germany

[5] Univ Hosp Leipzig, Leipzig, Germany

[6] Asklepios Klin St Georg, Hamburg, Germany

[7] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V403

引用

页码：123 / 123

页数：1

共 50 条

[31] RETROSPECTIVE EVALUATION OF IRON OVERLOAD PREVALENCE IN MYELODYSPLASTIC SYNDROMES AT THE DIAGNOSIS [J].

Ricerca, B. M. ;

Voso, M. T. ;

Greco, M. ;

Fianchi, L. ;

Pagano, L. ;

Giordano, G. ;

Piano, S. ;

Storti, S. ;

Leone, G. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 :532-532

[32] PRACTICAL CONSIDERATIONS IN TREATING PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND IRON OVERLOAD [J].

McKiernan, Phyllis ;

Shah, Jayshree .

ONCOLOGY NURSING FORUM, 2018, 45 (02)

[33] Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes [J].

Wimazal, F. ;

Noesslinger, T. ;

Baumgartner, C. ;

Sperr, W. R. ;

Pfeilstoecker, M. ;

Valent, P. .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (05) :406-411

[34] Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes Recent Developments [J].

Leitch, Heather A. .

DRUGS, 2011, 71 (02) :155-177

[35] Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload [J].

Gattermann, Norbert .

LEUKEMIA RESEARCH, 2007, 31 :S10-S15

[36] Regulation of Hepcidin and Iron-Overload Disease [J].

Lee, Pauline L. ;

Beutler, Ernest .

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :489-515

[37] A NEW CLASSIFICATION OF GENETIC IRON OVERLOAD SYNDROMES [J].

Yano, Motoyoshi ;

Miyajima, Hiroaki ;

Tomosugi, Naohisa ;

Wakusawa, Shinya ;

Yamashita, Tetsuji ;

Hattori, Ai ;

Tatsumi, Yasuaki ;

Kato, Koichi ;

Hayashi, Hisao .

AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) :E203-E203

[38] Liver-MRI as a routine screening method for iron-overload in patients with myelodysplasic syndromes [J].

Groepper, S. ;

Schmitz, A. ;

Erlemann, R. ;

Aul, C. ;

Giagounidis, A. .

ONKOLOGIE, 2011, 34 :145-145

[39] MRI and iron-overload cardiomyopathy in thalassaemia [J].

Owen, OG ;

Pennell, D .

CIRCULATION, 2006, 113 (11) :F43-F44

[40] INCREASED SERUM FERRITIN AND GENETIC INSTABILITY IN MYELODYSPLASTIC SYNDROMES [J].

Ganster, C. ;

Westhofen, G. ;

Beier, F. ;

Rassaf, T. ;

Al-Ali, H. K. ;

Stuhlmann, R. ;

Glass, B. ;

Martin, R. ;

Bacher, U. ;

Bruemmendorf, T. H. ;

Germing, U. ;

Gattermann, N. ;

Haase, D. .

LEUKEMIA RESEARCH, 2017, 55 :S37-S37

← 1 2 3 4 5 →